<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02486471</url>
  </required_header>
  <id_info>
    <org_study_id>COLPO-1</org_study_id>
    <nct_id>NCT02486471</nct_id>
  </id_info>
  <brief_title>Hemostatic Procedure After Biopsy of the Cervix</brief_title>
  <official_title>Is a Hemostatic Procedure Required After Biopsy of the Cervix Uteri in Women Undergoing Colposcopy for Cervical Dysplasia? A Multicenter Randomized Non-inferiority Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zydolab - Institute of Cytology and Immune Cytochemistry</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zydolab - Institute of Cytology and Immune Cytochemistry</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cytological abnormalities of the Cervix uteri need to be clarified by colposcopy biopsy. To
      avoid bleeding after biopsy, monsel´s paste is a common used Agent. In a randomized clinical
      Trial the use of monsel´s paste after biopsy will be compared to no Intervention. The Primary
      outcome of the study is blood loss, secondary outcomes are pain, satisfaction of the patient
      and influence of Independent factors such as Age and Body mass index.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Actual">February 2016</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood loss after 15 minutes (5-step visual analogue scale)</measure>
    <time_frame>15 minutes</time_frame>
    <description>blood loss 15 minutes after biopsy will be measured judging the amount of blood on the sanitary napkin (5-step visual analogue scale)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood loss after 3 hours (5-step visual analogue scale)</measure>
    <time_frame>3 hours</time_frame>
    <description>blood loss 3 hours after biopsy will be measured judging the amount of blood on the sanitary napkin (5-step visual analogue scale)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood loss after 6 hours (5-step visual analogue scale)</measure>
    <time_frame>6 hours</time_frame>
    <description>blood loss 6 hours after biopsy will be measured judging the amount of blood on the sanitary napkin (5-step visual analogue scale)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood loss after 24 hours (5-step visual analogue scale)</measure>
    <time_frame>24 hours</time_frame>
    <description>blood loss 24 hours after biopsy will be measured judging the amount of blood on the sanitary napkin (5-step visual analogue scale)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensation of pain after 15 minutes (10-step visual analogue scale)</measure>
    <time_frame>15 minutes</time_frame>
    <description>patients will score their pain Level using a 10-step visual analogue scale (VAS) 15 minutes after biopsy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Sensation of pain after 24 hours (10-step visual analogue scale)</measure>
    <time_frame>24 hours</time_frame>
    <description>patients will score their pain Level using a 10-step visual analogue scale (VAS) 24 hours after biopsy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Satisfaction of the Patient after 24 hours (10-step visual analogue scale)</measure>
    <time_frame>24 hours</time_frame>
    <description>patients will score their satisfaction Level using a 10-step visual analogue scale (VAS)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">166</enrollment>
  <condition>Uterine Cervical Dysplasia</condition>
  <arm_group>
    <arm_group_label>Observational approach</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Wait and see</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Use of Monsel´s Paste</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>cervical coagulation using a hemostatic agents, ie monsel´s paste</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Monsel´s Paste</intervention_name>
    <description>surgical method to stop bleeding by using the hemostatic Agent monsel´s paste until no more bleeding is visible</description>
    <arm_group_label>Use of Monsel´s Paste</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Wait and see</intervention_name>
    <description>finishing examination without hemostatic intervention, awaiting spontaneous coagulation</description>
    <arm_group_label>Observational approach</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  abnormal pap smear

          -  first colposcopy ever

        Exclusion Criteria:

          -  pregnancy

          -  bleeding disorder

          -  the use of blood thinner

          -  language barrier

          -  unwillingness to participate
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ziad Hilal, M. D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zydolab - Institute of Cytology and Immune Cytochemistry</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Zydolab - Institute of Cytology and Immune Cytochemistry</name>
      <address>
        <city>Dortmund</city>
        <state>NRW</state>
        <zip>44137</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Obstetrics and Gynecology of the Ruhr University Bochum</name>
      <address>
        <city>Herne</city>
        <state>NRW</state>
        <zip>44625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 28, 2015</study_first_submitted>
  <study_first_submitted_qc>June 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 1, 2015</study_first_posted>
  <last_update_submitted>February 13, 2016</last_update_submitted>
  <last_update_submitted_qc>February 13, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zydolab - Institute of Cytology and Immune Cytochemistry</investigator_affiliation>
    <investigator_full_name>Dr. med. Ziad Hilal</investigator_full_name>
    <investigator_title>Dr. med. Ziad Hilal</investigator_title>
  </responsible_party>
  <keyword>cervical dysplasia</keyword>
  <keyword>colposcopy</keyword>
  <keyword>haemostatic procedure</keyword>
  <keyword>biopsy of the cervix uteri</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Uterine Cervical Dysplasia</mesh_term>
    <mesh_term>Cervical Intraepithelial Neoplasia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemostatics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

